Human cancer inhibitory peptide amides

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 4 to 5 amino acid residues in defined sequence

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530331, 530321, A61K 3804, C07K 500

Patent

active

055300979

ABSTRACT:
This application discloses seven newly synthesized pentapeptide amides and our tetrapeptide amides. The synthesis utilized both naturally occurring and modified amino acids; the modified amino acids are constituents of the well known dolastatin 10 and dolastatin 15 which are structurally distinct peptides with excellent antineoplastic activity. These peptides were constructed by introducing a peptide bond between selected amino acids and modified amino acids and coupling the resulting di- and tri-peptides to obtain peptides having a high anticancer activity against a series of human cancer cell lines. ##STR1##

REFERENCES:
patent: 4816444 (1989-03-01), Pettit
patent: 5017691 (1991-05-01), Lee
patent: 5410024 (1995-04-01), Pettit et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Human cancer inhibitory peptide amides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human cancer inhibitory peptide amides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human cancer inhibitory peptide amides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2189829

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.